台灣骨碎補(ECAP)針對糖尿的研究

本月(2017.3.23)的國際醫學期刊(PLOS ONE),發表一篇由臻里生技提供指標成分,配合中國醫藥大學,署立豐原醫院和中台科技大學的共同發表。

文中指出台灣骨碎補的指標成分(ECAP)可以透過增加骨骼肌的葡萄糖轉化酶(GLUT4)的作用及增加AMPK,降低PPAR-gama,其結果對於糖尿病的預防起了很好的作用。

PLOS ONE | https://doi.org/10.1371/journal.pone.0173984 March 23, 2017

RESEARCH ARTICLE

(−)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice

Cheng-Hsiu Lin1☯, Jin-Bin Wu2☯, Jia-Ying Jian3 , Chun-Ching Shih3 *

1 Department of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City, Taiwan,

2 Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung City, Taiwan,

3 Graduate Institute of Biotechnology and Biomedical Engineering, College of Health Science, Central Taiwan University of Science and Technology, Taichung City, Taiwan

Back_to_top